Gianna Maria D’Elia

Author

Gianna Maria D’Elia

Also Known As

G M D'Elia, Gianna M. D'Elia, Gianna M. D’Elia, Gianna Maria D'Elia, Gianna Maria D'elia, Gianna Maria D’Elia, Gianna Maria D’elia, Gianna maria D'elia

Publications

651

Citations

H-Index

Concepts

All Affiliations

Sapienza University of Rome Policlinico Umberto I St. Eugenio Hospital Istituto Superiore di Sanità University of Cagliari

About

Gianna Maria D’Elia is an author at Sapienza University of Rome specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	250
2	Health Sciences	3	3	95
3	Public Health	1	1	38
4	Biostatistics	1	1	12
5	Cell Biology	1	1	15

Gianna Maria D’Elia

Publications

477

Citations

H-Index

Page 1

	Year	Citations
Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience Claudio Cartoni, Pasquale Niscola, Massimo Breccia, Leukemia & lymphoma/Leukemia and lymphoma	2009	56
Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: an Italian survey Pasquale Niscola, Claudio Cartoni, Claudio Romani, Annals of Hematology Family MedicinePain TherapyAdvanced Hematological MalignanciesPain MedicineHome Care Program	2007	50
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit. Corrado Girmenia, Giuliana Alimena, Roberto Latagliata, PubMed	1999	39
Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients Massimo Breccia, Vincenzo Federico, Roberto Latagliata, Leukemia Research Myelodysplastic Syndrome PatientsHematological MalignancyBone Marrow FailureAplastic AnemiaClinical Epidemiology	2010	38
Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study Federico De Angelis, Maria Elena Tosti, Saveria Capria, Leukemia Research Indolent Non-hodgkin LymphomasLymphoid NeoplasiaRetrospective Cohort StudyMedicineImmunodeficiencies	2015	38
Granulocytic sarcoma of the pancreas successfully treated with intensive chemotherapy and stem cell transplantation Massimo Breccia, Mariella D’Andrea, Andrea Mengarelli, European Journal Of Haematology	2003	29
Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era Salvatore Perrone, Gianna Maria D’Elia, Giorgia Annechini, Leukemia Research Prognostic FactorsLymphoid NeoplasiaSurgical OncologyMedicineWait Policy	2016	27
Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma Claudio Cartoni, Gregorio Antonio Brunetti, Vincenzo Federico, Supportive Care in Cancer Neuro-oncologyControlled-release OxycodoneInterventional Pain MedicineHealth SciencesPain Medicine	2012	25
Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI‐1‐positive, 3q21q26 syndrome and T cell‐line antigen expression: what is the EVI‐1 gene role? Massimo Breccia, Maria Concetta Petti, Emanuela Ottaviani, British Journal of Haematology	2002	25
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy Alessandro Pulsoni, Irene Della Starza, Luca Vincenzo Cappelli, British Journal of Haematology	2019	22

Page 1